Swedish study: active surveillance of prostate cancer leads to more deaths than getting treatment

URO TODAY: Men who choose watchful waiting after diagnosis of prostate cancer face higher risk of death from the disease than those who choose treatment, a Swedish study of nearly 7000 men has shown. READ MORE> After adjustment for risk category, co-morbidity, and socio-economic status, there was a lower risk of prostate cancer-specific death in [...]

Read Full Post »

Programme developed for managing uncertainty of active surveillance

URO TODAY:  An “uncertainty management” model developed for people being treated for breast or prostate cancer has been revamped for those who chose active surveillance when diagnosed with prostate cancer. READ MORE>

Read Full Post »

Active surveillance may not be wise choice for younger men with low risk prostate cancer

URO TODAY: Watchful waiting may not be a wise choice for younger men diagnosed with low risk prostate cancer, a new study suggests. Our pathologic findings and risk of biochemical recurrence after open radical prostatectomy question the wisdom of active surveillance in men with low-risk disease who have “long” life expectancies. READ MORE>

Read Full Post »

Long-term survival for prostate cancer worse if you choose ‘watchful waiting’

UPI: Prostate cancer patients who refuse treatment don’t do as well as those who choose radiation treatment, US researchers found. READ MORE> Researchers at Henry Ford Hospital in Detroit found the 10-year overall survival rate for men who chose “watchful waiting” was 51 percent. It was 68 percent for those who had radiation treatment. URO [...]

Read Full Post »

Active surveillance appropriate for low-risk prostate cancer, studies show

URO TODAY: Active surveillance protocols can be valuable when prostate cancer is managed well and treatment is recommended appropriately, according to two recent studies. READ MORE>

Read Full Post »

What to do about a prostate cancer diagnosis – experts debate the options

URO TODAY: What do you do when you’re told you have prostate cancer – get treatment or wait and watch? A bunch of US experts have been debating the pros and cons of active surveillance. READ MORE>

Read Full Post »

More evidence emerges to support active surveillance as viable option for prostate cancer patients

NEW PROSTATE CANCER INFOLINK: Evidence is growing that active surveillance – watchful waiting – is a viable option for men diagnosed with prostate cancer, but more long-term data is needed on survival rates.

Read Full Post »

Current prostate cancer tests not good enough to decide when active surveillance is best option

URO TODAY: Current prostate cancer tests are not good enough to enable doctors to decide which patients should be left to active surveillance, a German study suggests.

Read Full Post »

Prostate cancer Gene 3 on its own not useful for predicting outcome in men under active surveillance

URO TODAY: Testing for prostate cancer Gene 3 in urine in men under active surveillance is not on its own a useful predictor of disease progression.

Read Full Post »

Serious doubts raised on viability of ‘watchful waiting’ option with prostate cancer

URO TODAY: Is leaving apparently low-grade prostate cancer alone and waiting to see what happens really a viable option?

Read Full Post »